Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:839-844

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevenson, K. M.
Right arrow Articles by Anderson, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevenson, K. M.
Right arrow Articles by Anderson, W. P.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Remodeling
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Hypertrophy
Right arrow Other Vascular biology
Right arrow Other Research

(Hypertension. 2000;36:839.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Angiotensin II Infused Intrarenally Causes Preglomerular Vascular Changes and Hypertension

Kathleen M. Stevenson; Amanda J. Edgley; Göran Bergström; Katrina Worthy; Michelle M. Kett; Warwick P. Anderson

From the Department of Physiology (K.M.S., A.J.E., K.W., M.M.K., W.P.A.), Monash University, Clayton, Victoria, Australia; and Department of Physiology (G.B.), Goteborg University, Goteborg, Sweden.

Correspondence to Dr Kathleen Stevenson, Department of Physiology, Monash University, Wellington Rd, Victoria 3800, Australia. E-mail kathleen.stevenson{at}med.monash.edu.au

Abstract—The effects on the renal vasculature and on arterial blood pressure of chronic infusion of low doses of angiotensin II (Ang II) into the renal artery were studied. Sprague Dawley rats were infused continuously with Ang II (0.5, 1.5, or 4.5 ng · kg-1 · min-1) or vehicle into the right renal artery (contralateral nephrectomy). Intrarenal Ang II infusion for 25 days produced dose-dependent rises (P<0.001) in awake mean arterial pressure (111±1, 119±5, and 130±3 mm Hg in rats receiving 0.5, 1.5, and 4.5 ng · kg-1 · min-1 Ang II, respectively) compared with 105±1 mm Hg (vehicle). Renal vessel lumen characteristics were assessed with an established, maximally dilated, isosmotic perfused kidney preparation. This revealed a small dose-dependent right shift in the pressure-flow relation (P=0.05), as well as a dose-dependent right shift and a dose-dependent reduction in the slope of the pressure–glomerular filtration rate relation (P=0.04 and 0.03, respectively). The effects of Ang II infusion on arterial pressure were not affected by the timing of the contralateral nephrectomy but were reduced when the contralateral kidney remained in situ. Acute losartan administration (10 mg/kg IV bolus) produced similar effects on arterial pressure in rats infused with vehicle or Ang II (4.5 ng · kg-1 · min-1) for 14 days, P=0.89), indicating the lack of systemic spillover of Ang II. Intraperitoneal Ang II (0.5, 1.5, or 4.5 ng · kg-1 · min-1 for 25 days) had no effect on arterial pressure. Thus, chronic intrarenal infusion of low doses of Ang II resulted in changes in the renal vasculature compatible with dose-related structural reductions in the lumen diameter of preglomerular vessels and produced dose-related increases in arterial pressure.


Key Words: angiotensin II • kidney • perfusion • rats • vascular resistance




This article has been cited by other articles:


Home page
J. Physiol.Home page
R. R. Singh, L. A. Cullen-McEwen, M. M. Kett, W.-M. Boon, J. Dowling, J. F. Bertram, and K. M. Moritz
Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring
J. Physiol., March 1, 2007; 579(2): 503 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Kawada, K. Dennehy, G. Solis, P. Modlinger, R. Hamel, J. T. Kawada, S. Aslam, T. Moriyama, E. Imai, W. J. Welch, et al.
TP receptors regulate renal hemodynamics during angiotensin II slow pressor response
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F753 - F759.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig
Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. C. Parkington, J. Dodd, S. E. Luff, K. Worthy, H. A. Coleman, M. Tare, W. P. Anderson, and A. J. Edgley
Selective Increase in Renal Arcuate Innervation Density and Neurogenic Constriction in Chronic Angiotensin II-Infused Rats
Hypertension, March 1, 2004; 43(3): 643 - 648.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Kawada, E. Imai, A. Karber, W. J. Welch, and C. S. Wilcox
A Mouse Model of Angiotensin II Slow Pressor Response: Role of Oxidative Stress
J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2860 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. Edgley, N. R. Nichols, and W. P. Anderson
Acute intrarenal infusion of ANG II does not stimulate immediate early gene expression in the kidney
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1133 - R1139.
[Abstract] [Full Text] [PDF]